Table 2.
Skin hyperkeratosis
|
|||||
---|---|---|---|---|---|
OGG1 expression | Absent | Present | OR (95% CI)a | p-Value | Trend p-value |
All subjects | |||||
0.38–1.17 | 56 | 18 | 1.00 (reference) | ||
1.17–1.53 | 54 | 21 | 1.33 (0.61–2.88) | 0.470 | |
1.54–2.01 | 47 | 28 | 2.21 (1.03–4.75) | 0.037 | 0.054b |
2.02–4.37 | 50 | 24 | 1.69 (0.78–3.66) | 0.180 | 0.099c |
Maled | |||||
0.38–1.17 | 32 | 9 | 1.00 (reference) | ||
1.17–1.53 | 33 | 9 | 1.06 (0.35–3.20) | 0.92 | |
1.54–2.01 | 22 | 13 | 2.73 (0.92–8.10) | 0.071 | 0.08 |
2.02–4.37 | 20 | 15 | 2.98 (1.02–8.75) | 0.047 | 0.02 |
Female | |||||
0.38–1.17 | 24 | 9 | 1.00 (reference) | ||
1.17–1.53 | 21 | 12 | 1.71 (0.57 –5.15) | 0.34 | |
1.54–2.01 | 25 | 15 | 1.83 (0.60–5.59) | 0.29 | 0.22 |
2.02–4.37 | 30 | 9 | 0.95 (0.30–3.01) | 0.93 | 0.92 |
Data shown are OR (95% CI) adjusted for sex, age, smoking, alcohol use, and pesticide use.
p-Value for trend across first three quartiles of OGG1 groups by Wald test.
p-Value for trend across all four quartile categories by Wald test.
Skin hyperkeratosis status was not ascertained for one male subject.